{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "meta-analysis", "ozone therapy", "standard treatment", "systematic review"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36438064", "DateRevised": {"Year": "2023", "Month": "11", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "11", "Day": "10"}], "ELocationID": ["1037749", "10.3389/fmed.2022.1037749"], "Journal": {"ISSN": "2296-858X", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in medicine", "ISOAbbreviation": "Front Med (Lausanne)"}, "ArticleTitle": "Efficacy of ozone adjuvant therapy in COVID-19 patients: A meta-analysis study.", "Pagination": {"StartPage": "1037749", "MedlinePgn": "1037749"}, "Abstract": {"AbstractText": ["Using ozone therapy to manage COVID-19 patients has been accompanied by conflicting results in prior studies. Therefore, we aimed to widely assess the effects of ozone as adjuvant therapy in COVID-19 patients.", "PubMed, Scopus, Web of Science, Cochrane, ProQuest, Springer, and Sage journals were searched systematically until April 2022. Mortality rate, ICU admission, hospital-length stay, negative PCR, pulmonary, renal, and hepatic functions, as well as inflammatory and blood systems were pooled to compare the efficacy of ozone as adjacent therapy (OZ) and standard treatment (ST). Analyses were run with the random/fixed models, sub-group analysis, funnel plot, and sensitivity analysis using comprehensive meta-analysis (CMA) software version 2.0.", "The results of four randomized clinical trials (RCTs) and four case-control studies with a total of 371 COVID-19 positive patients were analyzed. The OZ group patients had a shorter length of hospital stay (<i>P</i> > 0.05), lower ICU admissions (<i>P</i> > 0.05), and lower mortality rates (<i>P</i> < 0.05) than the ST group cases. After treatment, 41% more COVID-19 patients had negative PCR tests than the ST group (<i>P</i> < 0.05). Serum creatinine and urea levels were not modified in either group (<i>P</i> > 0.05). Moreover, except for albumin serum levels, which decreased significantly in the OZ group, serum bilirubin, ALT, and AST were not modified in either group (<i>P</i> > 0.05). Both arms did not show a decrease in C-reactive protein blood levels (<i>P</i> > 0.05), but the OZ group showed a significant modification in LDH serum levels (<i>P</i> < 0.05). Unlike the d-dimer and WBC serum levels (<i>P</i> > 0.05), platelet levels were increased in the OZ group (<i>P</i> < 0.05). No negative side effects were demonstrated in either group.", "Ozone therapy was effective significantly on PCR test and LDH serum levels, as well as mortality based on overall estimation. Concerning the length of hospital stay and ICU admissions, although the results were insignificant, their effect sizes were notable clinically. More RCT studies are needed to show the efficacy of ozone therapy on other studied variables."], "CopyrightInformation": "Copyright \u00a9 2022 Jafari-Oori, Vahedian-azimi, Ghorbanzadeh, Sepahvand, Dehi, Ebadi and Izadi."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Atherosclerosis Research Center, Faculty of Nursing, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Jafari-Oori", "ForeName": "Mehdi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Vahedian-Azimi", "ForeName": "Amir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nursing, Khalkhal University of Medical Sciences, Khalkhal, Iran."}], "LastName": "Ghorbanzadeh", "ForeName": "Kobra", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Social Determinants of Health Research Center, Poledokhtar School of Nursing, Lorestan University of Medical Sciences, Lorestan, Iran."}], "LastName": "Sepahvand", "ForeName": "Elham", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nursing, Maragheh University of Medical Sciences, Maragheh, Iran."}], "LastName": "Dehi", "ForeName": "Manijeh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Nursing, Behavioral Sciences Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Ebadi", "ForeName": "Abbas", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Izadi", "ForeName": "Mortaza", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Med (Lausanne)", "NlmUniqueID": "101648047", "ISSNLinking": "2296-858X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Izadi M, Cegolon L, Javanbakht M, Sarafzadeh A, Abolghasemi H, Alishiri G, et al. Ozone therapy for the treatment of COVID-19 pneumonia: a scoping review. Int Immunopharmacol. (2021) 92:107307. 10.1016/j.intimp.2020.107307", "ArticleIdList": ["10.1016/j.intimp.2020.107307", "PMC7752030", "33476982"]}, {"Citation": "\u00c7olak \u015e, Gen\u00e7 Yavuz B, Yavuz M, \u00d6z\u00e7elik B, \u00d6ner M, \u00d6zg\u00fcltekin A, et al. Effectiveness of ozone therapy in addition to conventional treatment on mortality in patients with COVID-19. Int J Clin Pract. (2021) 75:e14321. 10.1111/ijcp.14321", "ArticleIdList": ["10.1111/ijcp.14321", "PMC8236993", "33971067"]}, {"Citation": "Martins RB, Castro IA, Pontelli M, Souza JP, Lima TM, Melo SR, et al. SARS-CoV-2 inactivation by ozonated water: a preliminary alternative for environmental disinfection. Ozone Sci Eng. (2021) 43:108\u201311. 10.1080/01919512.2020.1842998", "ArticleIdList": ["10.1080/01919512.2020.1842998"]}, {"Citation": "World Health Organization [WHO]. WHO Coronavirus (COVID-19) Dashboard. Geneva: World Health Organization; (2020)."}, {"Citation": "Merks P, Religioni U, Bilmin K, Bogusz J, Juszczyk G, Bara\u00f1ska A, et al. Ozone disinfection of community pharmacies during the COVID-19 pandemic as a possible preventive measure for infection spread. Med Pr. (2021) 72:529\u201334. 10.13075/mp.5893.01091", "ArticleIdList": ["10.13075/mp.5893.01091", "34140707"]}, {"Citation": "Shah M, Captain J, Vaidya V, Kulkarni A, Valsangkar K, Nair PM, et al. Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: a phase 1/11 randomized control trial (SEOT study). Int Immunopharmacol. (2021) 91:107301. 10.1016/j.intimp.2020.107301", "ArticleIdList": ["10.1016/j.intimp.2020.107301", "PMC7758022", "33421928"]}, {"Citation": "Cattel F, Giordano S, Bertiond C, Lupia T, Corcione S, Scaldaferri M, et al. Ozone therapy in COVID-19: a narrative review. Virus Res. (2021) 291:198207. 10.1016/j.virusres.2020.198207", "ArticleIdList": ["10.1016/j.virusres.2020.198207", "PMC7585733", "33115670"]}, {"Citation": "Hern\u00e1ndez A, Vi\u00f1als M, Isidoro T, Vil\u00e1s F. Potential role of oxygen\u2013ozone therapy in treatment of COVID-19 pneumonia. Am J Case Rep. (2020) 21:e925849. 10.12659/AJCR.925849", "ArticleIdList": ["10.12659/AJCR.925849", "PMC7476746", "32804917"]}, {"Citation": "Sunnen GV. Ozone in medicine: overview and future directions. J Adv Med. (1988) 1:159\u201374."}, {"Citation": "Sallustio F, Cardinale G, Voccola S, Picerno A, Porcaro P, Gesualdo L. Ozone eliminates novel coronavirus Sars-CoV-2 in mucosal samples. New Microbes New Infect. (2021) 43:100927. 10.1016/j.nmni.2021.100927", "ArticleIdList": ["10.1016/j.nmni.2021.100927", "PMC8302481", "34336226"]}, {"Citation": "Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol. (2020) 92:2348\u201350. 10.1002/jmv.26040", "ArticleIdList": ["10.1002/jmv.26040", "PMC7280732", "32437014"]}, {"Citation": "Zeng J, Lei L, Zeng Q, Yao Y, Wu Y, Li Q, et al. Ozone therapy attenuates NF-\u03baB-mediated local inflammatory response and activation of Th17 cells in treatment for psoriasis. Int J Biol Sci. (2020) 16:1833. 10.7150/ijbs.41940", "ArticleIdList": ["10.7150/ijbs.41940", "PMC7211165", "32398953"]}, {"Citation": "Mazur-Panasiuk N, Botwina P, Kutaj A, Woszczyna D, Pyrc K. Ozone treatment is insufficient to inactivate SARS-CoV-2 surrogate under field conditions. Antioxidants. (2021) 10:1480. 10.3390/antiox10091480", "ArticleIdList": ["10.3390/antiox10091480", "PMC8470094", "34573110"]}, {"Citation": "Sharma A, Shah M, Lakshmi S, Sane H, Captain J, Gokulchandran N, et al. A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial. Int Immunopharmacol. (2021) 96:107743. 10.1016/j.intimp.2021.107743", "ArticleIdList": ["10.1016/j.intimp.2021.107743", "PMC8084612", "33984718"]}, {"Citation": "Marini S, Maggiorotti M, Dardes N, Bonetti M, Martinelli M, Re L, et al. Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study. J Biol Regul Homeost Agents. (2020) 34:757\u2013766.", "ArticleIdList": ["32462858"]}, {"Citation": "Franzini M, Valdenassi L, Ricevuti G, Chirumbolo S, Depfenhart M, Bertossi D, et al. Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int Immunopharmacol. (2020) 88:106879. 10.1016/j.intimp.2020.106879", "ArticleIdList": ["10.1016/j.intimp.2020.106879", "PMC7414302", "32795898"]}, {"Citation": "Dengiz E, \u00d6zcan \u00c7, G\u00fcven Y\u00dd, U\u00e7ar S, Ener BK, S\u00f6zen S. Ozone gas applied through nebulizat\u0131on as adjuvant treatment for lung respiratory d\u0131seases due to COVID-19 infect\u0131ons: a prospective randomized trial. Med Gas Res. (2022) 12:55.", "ArticleIdList": ["PMC8562398", "34677153"]}, {"Citation": "Yousefi B, Banihashemian SZ, Feyzabadi ZK, Hasanpour S, Kokhaei P, Abdolshahi A, et al. Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease. Med Gas Res. (2022) 12:33.", "ArticleIdList": ["PMC8562402", "34677149"]}, {"Citation": "Chirumbolo S, Valdenassi L, Simonetti V, Bertossi D, Ricevuti G, Franzini M, et al. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol. (2021) 96:107777. 10.1016/j.intimp.2021.107777", "ArticleIdList": ["10.1016/j.intimp.2021.107777", "PMC8112288", "34020394"]}, {"Citation": "Blanco A, Ojembarrena FDB, Clavo B, Negro C. Ozone potential to fight against SAR-COV-2 pandemic: facts and research needs. Environ Sci Pollut Res. (2021) 28:16517\u201331. 10.1007/s11356-020-12036-9", "ArticleIdList": ["10.1007/s11356-020-12036-9", "PMC7778500", "33389580"]}, {"Citation": "Budi DS, Rofananda IF, Pratama NR, Sutanto H, Hariftyani AS, Desita SR, et al. Ozone as an adjuvant therapy for COVID-19: a systematic review and meta-analysis. Int Immunopharmacol. (2022) 110:109014. 10.1016/j.intimp.2022.109014", "ArticleIdList": ["10.1016/j.intimp.2022.109014", "PMC9250927", "35803132"]}, {"Citation": "Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. (2009) 62:e1\u201334. 10.1016/j.jclinepi.2009.06.006", "ArticleIdList": ["10.1016/j.jclinepi.2009.06.006", "19631507"]}, {"Citation": "Higgins JP, Savovi\u00e6 J, Page MJ, Sterne JA. Revised Cochrane Risk-of-Bias Tool for Randomized Trials (RoB 2). Bristol: University of Bristol; (2016)."}, {"Citation": "Huedo-Medina TB, S\u00e1nchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?. Psychol Methods. (2006) 11:193. 10.1037/1082-989X.11.2.193", "ArticleIdList": ["10.1037/1082-989X.11.2.193", "16784338"]}, {"Citation": "Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. (2002) 21:1539\u201358. 10.1002/sim.1186", "ArticleIdList": ["10.1002/sim.1186", "12111919"]}, {"Citation": "Valentine JC, Pigott TD, Rothstein HR. How many studies do you need? A primer on statistical power for meta-analysis. J Educ Behav Stat. (2010) 35:215\u201347. 10.3102/1076998609346961", "ArticleIdList": ["10.3102/1076998609346961"]}, {"Citation": "Shrier I, Boivin J-F, Steele RJ, Platt RW, Furlan A, Kakuma R, et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol. (2007) 166:1203\u20139. 10.1093/aje/kwm189", "ArticleIdList": ["10.1093/aje/kwm189", "17712019"]}, {"Citation": "Bun R-S, Scheer J, Guillo S, Tubach F, Dechartres A. Meta-analyses frequently pooled different study types together: a meta-epidemiological study. J Clin Epidemiol. (2020) 118:18\u201328. 10.1016/j.jclinepi.2019.10.013", "ArticleIdList": ["10.1016/j.jclinepi.2019.10.013", "31698062"]}, {"Citation": "Araimo F, Imperiale C, Tordiglione P, Ceccarelli G, Borrazzo C, Alessandri F, et al. Ozone as adjuvant support in the treatment of COVID-19: a preliminary report of probiozovid trial. J Med Virol. (2021) 93:2210\u201320. 10.1002/jmv.26636", "ArticleIdList": ["10.1002/jmv.26636", "33111980"]}, {"Citation": "Fern\u00e1ndez-Cuadros ME, Albaladejo-Flor\u00edn MJ, \u00c1lava-Rabasa S, Gallego-Galiana J, P\u00e9rez-Cruz GF, Usandizaga-Elio I, et al. Compassionate use of rectal Ozone (O3) in severe COVID-19 pneumonia: a case-control study. SN Compr Clin Med. (2021) 3:1185\u201399. 10.1007/s42399-021-00849-9", "ArticleIdList": ["10.1007/s42399-021-00849-9", "PMC7984736", "33778374"]}, {"Citation": "Sozio E, De Monte A, Sermann G, Bassi F, Sacchet D, Sbrana F, et al. CORonavirus-19 mild to moderate pneumonia management with blood ozonization in patients with respiratory failure (CORMOR) multicentric prospective randomized clinical trial. Int Immunopharmacol. (2021) 98:107874. 10.1016/j.intimp.2021.107874", "ArticleIdList": ["10.1016/j.intimp.2021.107874", "PMC8196321", "34186281"]}, {"Citation": "Tascini C, Sermann G, Pagotto A, Sozio E, De Carlo C, Giacinta A, et al. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience. Intern Emerg Med. (2021) 16:669\u201375. 10.1007/s11739-020-02542-6", "ArticleIdList": ["10.1007/s11739-020-02542-6", "PMC7603641", "33131033"]}, {"Citation": "Hern\u00e1ndez A, Vi\u00f1als M, Pablos A, Vil\u00e1s F, Papadakos PJ, Wijeysundera DN, et al. Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study. Int Immunopharmacol. (2021) 90:107261. 10.1016/j.intimp.2020.107261", "ArticleIdList": ["10.1016/j.intimp.2020.107261", "PMC7833586", "33310665"]}, {"Citation": "Hernandez A, Vinals M, Pablos A, Vilas F, Papadakos PJ, Wijeysundera DN, et al. Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study. Int Immunopharmacol. (2021) 90:107261.", "ArticleIdList": ["PMC7833586", "33310665"]}, {"Citation": "Fernandez-Cuadros ME, Albaladejo-Florin MJ, Alava-Rabasa S, Usandizaga-Elio I, Martinez-Quintanilla Jimenez D, Pena-Lora D, et al. Effect of Rectal ozone (O3) in severe COVID-19 pneumonia: preliminary results. SN Compr Clin Med. (2020) 2:1328\u201336. 10.1007/s42399-020-00374-1", "ArticleIdList": ["10.1007/s42399-020-00374-1", "PMC7397966", "32838181"]}, {"Citation": "Schwartz A, Mart\u00ednez-S\u00e1nchez G, de Luc\u00eda AM, Viana SM, Mita CA. Complementary application of the ozonized saline solution in mild and severe patients with pneumonia COVID-19: a non-randomized pilot study. Pharmacol Toxicol. (2020) 9:126\u2013142. 10.56499/jppres20.971_9.2.126", "ArticleIdList": ["10.56499/jppres20.971_9.2.126", "26173250"]}, {"Citation": "Williamson BN, Feldmann F, Schwarz B, Meade-White K, Porter DP, Schulz J, et al. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. (2020) 585:273\u20136. 10.1038/s41586-020-2423-5", "ArticleIdList": ["10.1038/s41586-020-2423-5", "PMC7486271", "32516797"]}, {"Citation": "Razzaq HA, Hasan MS, Al-Dhalemy MF, Al-Silaykhee WM, Alhmadi HB, Majeed ZA. Utilization of ozone as a complementary therapy for COVID-19 patients. Int J Psychosocial Rehab. (2020) 24:10577\u201388."}, {"Citation": "Clavo B, Rodr\u00edguez-Esparrag\u00f3n F, Rodr\u00edguez-Abreu D, Mart\u00ednez-S\u00e1nchez G, Llontop P, Aguiar-Bujanda D, et al. Modulation of oxidative stress by ozone therapy in the prevention and treatment of chemotherapy-induced toxicity: review and prospects. Antioxidants. (2019) 8:588. 10.3390/antiox8120588", "ArticleIdList": ["10.3390/antiox8120588", "PMC6943601", "31779159"]}, {"Citation": "Kahle JJ, Neas LM, Devlin RB, Case MW, Schmitt MT, Madden MC, et al. Interaction effects of temperature and ozone on lung function and markers of systemic inflammation, coagulation, and fibrinolysis: a crossover study of healthy young volunteers. Environ Health Perspect. (2015) 123:310\u20136.", "ArticleIdList": ["PMC4384199", "25514459"]}, {"Citation": "Bocci V. Is it true that ozone is always toxic. The end of the dogma. Toxicol Appl Pharmacol. (2006) 216:493\u2013504. 10.1016/j.taap.2006.06.009", "ArticleIdList": ["10.1016/j.taap.2006.06.009", "16890971"]}, {"Citation": "Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo A, Tirelli U. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci. (2020) 24:4059\u201361.", "ArticleIdList": ["32374009"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "7"}, {"Year": "2022", "Month": "10", "Day": "19"}, {"Year": "2022", "Month": "11", "Day": "28", "Hour": "4", "Minute": "9"}, {"Year": "2022", "Month": "11", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "11", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["36438064", "PMC9685165", "10.3389/fmed.2022.1037749"]}}], "PubmedBookArticle": []}